Patents

[Photo by Helloquence on Unsplash]
However, the pendulum may be swinging back the other way. There has been a recent trend at the Patent Appeals Board to strike down fewer patents. The pending Oil States case before the Supreme Court challenging the constitutionality of IPRs could possibly wipe out IPRs entirely, making it more difficult and costly to challenge patents. Also, the proposed STRONGER Patents Act has additional provisions that make challenging patents procedurally more difficult. This could possibly spur innovation further, as medical device companies gain additional confidence in the strength and value of patents.” —Bryan Wahl, partner at Knobbe Martens
In the year 2018, device industry must cohesively work more with Pharma companies to add value to the life of the patients. The disease and the disease patterns are changing & so the long term outcomes. Doctors / practitioners/ Companies & regulatory authorities must look at the side effects of post implantation of a device and prescribe medications so that long term outcomes of the patients are better with low side effects. Not all patients globally have an insurance Cover. Adipose tissue derived autologous Stem Cells treatment must get speedy approvals from regulatory authorities.